75 related articles for article (PubMed ID: 1165880)
1. Factors affecting survival in stage I and state II carcinoma of the cervix.
Welander CE; Montana GS; Saylor WL; Palumbo L; Fowler W
Obstet Gynecol; 1975 Oct; 46(4):439-43. PubMed ID: 1165880
[TBL] [Abstract][Full Text] [Related]
2. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results.
Chatani M; Matayoshi Y; Masaki N; Teshima T; Inoue T
Strahlenther Onkol; 1994 Nov; 170(11):636-42. PubMed ID: 7974179
[TBL] [Abstract][Full Text] [Related]
4. [Results of radiation therapy for cancer of the uterine cervix].
Kodama T; Koga K; Mori N; Fujisaki S; Haruyama Y; Nishikawa K; Jinnouchi S; Nakayama S; Watanabe K
Gan No Rinsho; 1983 Nov; 29(14):1647-50. PubMed ID: 6663711
[TBL] [Abstract][Full Text] [Related]
5. Long term follow-up results of high-dose rate remote afterloading intracavitary radiation therapy for carcinoma of the uterine cervix.
Chatani M; Matayoshi Y; Masaki N; Teshima T; Inoue T
Strahlenther Onkol; 1994 May; 170(5):269-76. PubMed ID: 8197549
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
7. Low morbidity following 9,000-rad intracavitary endocurietherapy (ECT) using the Kumar Cervical Applicator and external-beam radiotherapy (EXRT) in the management of carcinoma of the uterine cervix.
Kumar PP; Good RR; Scott JC; Jones EO; Lynch G; McCaul GF
Radiat Med; 1988; 6(2):92-106. PubMed ID: 3140299
[TBL] [Abstract][Full Text] [Related]
8. [The treatment of uterine carcinomas. A report on the cure results at the Hannover Medical College].
Feldmann HJ; Gefeller D; Majewski A
Strahlenther Onkol; 1991 Aug; 167(8):452-60. PubMed ID: 1887361
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized study concerning to the point A dose in high-dose rate intracavitary radiation therapy for carcinoma of the uterine cervix.
Chatani M; Teshima T; Inoue T
Strahlenther Onkol; 1991 Dec; 167(12):701-7. PubMed ID: 1763406
[TBL] [Abstract][Full Text] [Related]
11. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
12. Radical radiation therapy for adenocarcinoma of the uterine cervix.
Toita T; Takizawa Y; Nakano M; Sueyama H; Kushi A; Kakihana Y; Ogawa K; Hara R; Higashi M; Sakumoto K
Strahlenther Onkol; 1994 May; 170(5):277-80. PubMed ID: 8197550
[TBL] [Abstract][Full Text] [Related]
13. Results of radiation therapy in stage 1B cervical carcinoma at King Chulalongkorn Memorial Hospital: fifteen-year experience.
Lertbutsayanukul C; Lertsanguansinchai P; Shotelersuk K; Khorprasert C; Rojpornpradit P; Asavametha N; Pataramontree J; Suriyapee S; Tresukosol D; Termrungruanglert W
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S216-27. PubMed ID: 11529337
[TBL] [Abstract][Full Text] [Related]
14. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
[TBL] [Abstract][Full Text] [Related]
15. The time dose fractionation (TDF) relationship in the radiotherapy of carcinoma of the cervix.
Swamy K; Supe S; Kumar MU; Viswanathan N; Anantha N
Strahlenther Onkol; 1991 Oct; 167(10):603-7. PubMed ID: 1948645
[TBL] [Abstract][Full Text] [Related]
16. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
[TBL] [Abstract][Full Text] [Related]
17. Clinical results of medium dose rate brachytherapy combined with external beam radiotherapy in the treatment of advanced cervical carcinoma.
Ordeanu C; Coza O; Gavris S; Todor N; Szilagy E; Bako M; Cernea V; Ghilezan N; Nagy V
J BUON; 2007; 12(2):221-6. PubMed ID: 17600876
[TBL] [Abstract][Full Text] [Related]
18. [Short-term and end-results of combined treatment of patients with stage-II cervical cancer].
Vishnevskaia EE; Okeanova NI; Mamylevich OP
Vopr Onkol; 1999; 45(4):416-9. PubMed ID: 10532102
[TBL] [Abstract][Full Text] [Related]
19. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.
Gasinska A; Fowler JF; Lind BK; Urbanski K
Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186
[TBL] [Abstract][Full Text] [Related]
20. The dose time relationship in the radiotherapy of carcinoma of the cervix--application of CRE formalism.
Supe SS; Swamy K; Viswanathan N; Kumar MU; Anantha N
Indian J Cancer; 1992 Sep; 29(3):148-58. PubMed ID: 1292998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
